Haemonetics (HAE) has strong growth prospects and is a promising choice for growth investors.

From Nasdaq: 2024-05-27 12:45:09

Growth investors seek stocks with strong financial growth, but finding the right pick can be challenging due to volatility and risk. The Zacks Growth Style Score simplifies the process by analyzing a company’s growth prospects, like Haemonetics (HAE), which has a favorable Growth Score and top Zacks Rank. Factors like earnings growth, asset utilization ratio, and earnings estimate revisions make it a promising choice for growth investors. Haemonetics is well-positioned for outperformance based on these metrics.

Bitcoin has outperformed all other asset classes, with significant returns during past presidential election years. In 2012, returns were +272.4%, in 2016 +161.1%, and in 2020 +302.8%. Zacks predicts another surge in the coming months, making it an attractive investment opportunity for investors seeking high returns. Download the free special report to learn more.



Read more at Nasdaq: 3 Reasons Why Growth Investors Shouldn’t Overlook Haemonetics (HAE)